LINTUZUMAB SATETRAXETAN AC-225

UNII:	V860J30J9N
Formula:
Preferred Substance Name:	LINTUZUMAB SATETRAXETAN AC-225
GSRS Full Record:	V860J30J9N i

2209911-94-2
225AC-HUM195
225AC-LINTUZUMAB
ACTIMAB-A
ACTINIUM (225AC) LINTUZUMAB SATETRAXETAN
ACTINIUM (225AC) LINTUZUMAB SATETRAXETAN [INN]
ACTINIUM (225AC) LINTUZUMAB SATETRAXETAN [WHO-DD]
ACTINIUM AC 225 LINTUZUMAB
ACTINIUM AC-225 LINTUZUMAB
ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HUM195
HUM-195 AC-225
LINTUZUMAB ACTINIUM AC-225
SGN-33 AC-225

Common Chemistry
i
Inxight Drugs
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LINTUZUMAB SATETRAXETAN AC-225

Synonyms and Mappings

Resources